How to apply for this VCT
- Click on the Download pack button below to obtain all relevant literature.
- Read all the literature provided in full, ensuring you’re happy to proceed.
- Write a cheque made payable to the provider. Post it along with the completed documents and two valid forms of ID, to: WealthMe, PO Box 362, Burgess Hill, West Sussex, RH15 5BH.
Free VCT Guide
Download our free & comprehensive guide to VCTs.
All investment decisions must be made solely on the fund's prospectus.
Fund title: Foresight Williams Technology
*Rebate - Total 5% for NEW clients —ie Initial commission rebate of 3%, PLUS trail commission up to max 3% (ie 0.50% X 6 years) which is dependent on the investment being kept for the full term, LESS the 1% WealthMe Arrangement Fee which is paid by the product provider from the Initial commission.
If applicable, we will ask the product provider to reinvest any initial or trail commission back into your plan. This will be either in the form of a reduction in their charges or an enhancement of additional shares. However, if this cannot be facilitated, they will pay any initial or trail commission to WealthMe. We will then pay any surplus initial commission immediately back to the recipient. Any trail commission we receive will be paid to the recipient in January based on the amount received in the previous year (subject to a £10 administration fee). All initial and trail rebates will be paid net of basic rate tax and are to be treated as taxable income by the recipient as stipulated by HMRC.
WealthMe Arrangement Fee
Expected Close date
18 Dec 2020
Funds Raised and sought
£2.3m of £20m
The information given here has been taken from the product terms and conditions, brochure, and other literature available from the product provider. However, no guarantee can be made to the accuracy of the information. You should therefore satisfy yourself as to the full terms and risks of any investment by reference to the relevant materials provided by the product provider. In the unlikely event of any discrepancy between the information shown here and that provided in the provider literature, the product literature shall prevail. All investment involves risk and you could lose some or all of the money you invest.